Selective endothelin A receptor antagonism with sitaxsentan for pulmonary arterial hypertension associated with connective tissue disease
about
Endothelin receptor antagonists for pulmonary arterial hypertensionBiomarkers for pediatric pulmonary arterial hypertension - a call to collaboratePharmacokinetic drug evaluation of selexipag for the treatment of pulmonary arterial hypertension.Life-threatening complications of adult-onset Still's disease.Hemodynamics in pulmonary arterial hypertension (PAH): do they explain long-term clinical outcomes with PAH-specific therapy?Poor survival in patients with scleroderma and pulmonary hypertension due to heart failure with preserved ejection fractionTherapy for pulmonary arterial hypertension associated with systemic sclerosis.Hemodynamic predictors of survival in scleroderma-related pulmonary arterial hypertension.Erythroid-specific transcriptional changes in PBMCs from pulmonary hypertension patientsCardiovascular biomarkers in exhaled breathTreatment of pulmonary hypertension in patients with connective tissue disease and interstitial lung diseaseLung involvement in systemic sclerosis.Pulmonary arterial hypertension associated with systemic sclerosis.Vascular involvement in systemic sclerosis (scleroderma).Comparison of Treatment Response in Idiopathic and Connective Tissue Disease-associated Pulmonary Arterial HypertensionInhibition of endothelin receptors in the treatment of pulmonary arterial hypertension: does selectivity matter?Optimizing endothelin receptor antagonist use in the management of pulmonary arterial hypertension.Efficacy and safety of atrasentan in patients with cardiovascular risk and early atherosclerosisAssociation Between Initial Oral Therapy and Outcomes in Systemic Sclerosis-Related Pulmonary Arterial Hypertension.Health-related quality of life and patient-reported outcomes in pulmonary arterial hypertension.Therapies for scleroderma-related pulmonary arterial hypertensionExhaled nitric oxide as a biomarker in COPD and related comorbidities.Interstitial lung disease increases mortality in systemic sclerosis patients with pulmonary arterial hypertension without affecting hemodynamics and exercise capacity.The 6-minute walk test in scleroderma--how measuring everything measures nothing.Systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease: Impact of pulmonary arterial hypertension therapies
P2860
Q24240009-00FCC5FF-40BB-4F88-911F-EE8470ED4D21Q27026465-43215510-3072-4431-A114-AE8A0A7B9157Q30244352-1ED1B0CC-751F-494B-9731-DEC96F99C81DQ33412732-12F93D21-CAFD-45FA-B329-37811A550336Q33532813-566F9AED-ABA2-45F1-9EC8-AB385DFB0181Q33788474-7F4B6C88-E6E0-4054-9293-FD2540DC6B99Q33805746-4624D2B5-D72F-4604-ADCA-10D35A7ED7F6Q34032884-7E2D0FBC-5D15-4EF6-8493-66D273B09A72Q34251071-43667518-557A-4D08-8006-4647839CEAA3Q34384531-57CDF66B-3A79-470D-906E-10234FFF1797Q34425493-66E98F58-BCC3-40A7-98C7-A0ED53816E89Q34732817-9948D9D5-22DE-49BE-8ECC-BAA309485E3AQ35002423-8AE72928-0605-4E6C-81B6-8F2647D32A40Q35557424-76CE771D-2870-4366-81E8-815796588C7CQ36272410-B4B71965-53C5-4D58-AF5C-A50348DE43E1Q36836706-94D72FC5-ADCD-434B-A1F3-8B0576A7708FQ37019838-420A2628-499A-4662-8F20-2D163C4441D4Q37174006-4B1D38E0-43A3-416F-95A1-775F229FC6B8Q37200751-9D8AE8F4-A101-4D7C-ABF5-1C10719F23CDQ37215969-60E4A447-A865-46E2-A296-3F1A6A7B6691Q37364799-00CB9D71-B229-4DD9-A479-91CD82BF15DAQ38203516-C662EFB2-5BA6-416C-B342-3D4B1C4158D9Q39061311-6E29D4EF-5FD3-4145-9B2C-4B3DBD439E44Q39210409-91E59072-ADC2-4BBE-881C-8C5E1815438BQ56978031-C1B3509F-BA0F-43E3-99B7-E72A2852632C
P2860
Selective endothelin A receptor antagonism with sitaxsentan for pulmonary arterial hypertension associated with connective tissue disease
description
2007 nî lūn-bûn
@nan
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Selective endothelin A recepto ...... with connective tissue disease
@ast
Selective endothelin A recepto ...... with connective tissue disease
@en
Selective endothelin A recepto ...... with connective tissue disease
@nl
type
label
Selective endothelin A recepto ...... with connective tissue disease
@ast
Selective endothelin A recepto ...... with connective tissue disease
@en
Selective endothelin A recepto ...... with connective tissue disease
@nl
prefLabel
Selective endothelin A recepto ...... with connective tissue disease
@ast
Selective endothelin A recepto ...... with connective tissue disease
@en
Selective endothelin A recepto ...... with connective tissue disease
@nl
P2093
P2860
P356
P1476
Selective endothelin A recepto ...... with connective tissue disease
@en
P2093
Adaani E Frost
David Langleben
Evelyn M Horn
Ivan M Robbins
James R Seibold
Nicholas S Hill
Reda E Girgis
Robyn J Barst
Ronald J Oudiz
Shelley Shapiro
P2860
P304
P356
10.1136/ARD.2007.069609
P407
P577
2007-11-01T00:00:00Z